Introduction
The purpose of this work was to elucidate whether the release of bradykinin in the pancreRelease of bradykinin has been demonstrated atic gland is more profuse during taurocholateduring acute pancreatitis and is proposed to con-induced pancreatitis in rat, often leading to tribute to the development of hypotension and shock, than during caerulein-induced pancreatitis.
shock. ' procedure did not cause any significant inflamSamples of venous blood were drawn at 0 h, matory reaction. The microscopic appearance of 2h and 6 h into EDTA-containing tubes. After the pancreas was essentially normal after 6 h of centrifugation, the plasma samples were stored at microdialysis (Fig. 1 ).
-20C until analysed.
The concentration of bradykinin in the microAll animals surviving the observation period dialysate from taurocholate rats showed a rapid were killed with an overdose of mebumal. The study was approved by the ethics committee of tund University.
Assays: Bradykinin was measured using a radioimmunoassay technique described previously. increase, with a mean maximum value of 3.5 l.tg/1 1 hour after induction of the pancreatitis (Fig. 2) .
The level was significantly increased for about 4 h compared with the control rats. The increase in bradykinin concentration in the dialysates from the animals with caerulein-induced pancreatitis was modest and did not differ significantly from that of the control group.
The caerulein group showed the most pronounced increase in amylase levels with a mean value of 450 t.tcat/1 after 6 h. In comparison, the mean value of the taurocholate group was 180 I.tcat/1 and the control group 70 t.tcat/1 after 6 h (Fig. 3) .
The plasma concentration of t2-AP increased in all three groups, but the most pronounced increase was seen in the taurocholate group (Fig. 4) . 4 The severity of the disease is also illustrated by the pronounced release of bradykinin within the gland, as evidenced by the high levels in the dialysate. These results are also in agreement with earlier, more indirect, findings indicating that the kinin release in acute pancreatitis was localized to the abdominal region, as illustrated by kininogen consumption in the peritoneal exudates. 2 The very rapid acute phase protein ai-AP showed much higher plasma levels in the taurocholate group than in the caerulein group and in the controls, reflecting the more severe inflammation in the taurocholate group.
In conclusion, microdialysis appears to offer a convenient method of monitoring the intra-pancreatic release of bradykinin and should also be applicable to the study of other peptides. Severe pancreatitis appears to be accompanied by an extensive release of bradykinin within the gland, probably contributing to the oedema and tissue damage seen in this disease.
